Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1207017 NEW YORK, NY

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$5,482,571
-$559,818 QoQ
Shares Held
246,297
+8.9% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 90.72826709216922.ToString("F0")% Shared 0.ToString("F0")% None 9.27173290783079.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LAZARD ASSET MANAGEMENT LLC holds $361,300,548 across 55 Biotechnology names. ACAD ranks #10 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,482,571 246,297
2025-12-31 $6,042,389 226,222
2025-09-30 $3,688,000 172,821
2025-06-30 $767,264 35,571
2025-03-31 $3,114,390 187,501
2024-12-31 $2,769,527 150,928
2024-09-30 $1,492,519 97,043
2024-06-30 $549,769 33,832
2024-03-31 $484,678 26,213
2023-12-31 $265,946 8,494
2023-09-30 $132,562 6,361
2023-06-30 $98,793 4,125
2023-03-31 $57,156 3,037
2022-09-30 $60,352 3,689
2021-12-31 $72,704 3,115
2021-09-30 $43,335 2,609
2020-12-31 $72,491 1,356
2020-09-30 $55,935 1,356
2020-03-31 $171,535 4,060